Curaleaf

Fab 5 Freddy, Bernard Noble and Curaleaf Continue National Roll Out of B NOBLE Brand to Six New States

Wednesday, October 20, 2021 - 1:00pm

WAKEFIELD, Mass., Oct. 20, 2021 /PRNewswire/ -- B NOBLE Inc. and Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer products in cannabis, today announced the continuation of its national roll out of the B NOBLE brand two-pack pre-rolls to dispensaries in Arizona, Illinois, Maine, Michigan, Nevada, and Oregon. Since rolling out in July 2021 in Massachusetts and Maryland, today B NOBLE is now available in eight states.

Key Points: 
  • Since rolling out in July 2021 in Massachusetts and Maryland, today B NOBLE is now available in eight states.
  • Each B Noble Pre-Roll pack contains two One Gram pre-rolls for a total of Two Grams of cannabis.
  • "Our partnership with Curaleaf is our deeper dive into dedicated social equity work," said Fab 5 Freddy.
  • "B NOBLE exists to generate support for the defense of people impacted by the War on Drugs."

Rising Consumer Spending on CBD-infused Products Fueling Big Profits in Billion Dollar Industry

Thursday, October 14, 2021 - 1:50pm

Nowadays, the demand for cannabis is expected to increase significantly from the arrival of cannabis-infused products.

Key Points: 
  • Nowadays, the demand for cannabis is expected to increase significantly from the arrival of cannabis-infused products.
  • The growth of the overall CBD-infused products market is backed by the rising demand and increasing legalization of cannabis, growing application of cannabis in cancer, and health benefits offered by cannabis-infused products.
  • As a result, CBD-infused product sales are soaring, ultimately driving the growth of the CBD-infused products market.
  • "According to Bloomberg , Thrasio, having raised more than $2 billion, could see its IPO valued at more than $10 billion.

Rising Consumer Spending on CBD-infused Products Fueling Big Profits in Billion Dollar Industry

Thursday, October 14, 2021 - 1:50pm

PALM BEACH, Fla., Oct. 14, 2021 /PRNewswire/ -- The last two decades have seen a great deal of progress in global legalization and regulation of cannabis, both for medical and recreational use. Nowadays, the demand for cannabis is expected to increase significantly from the arrival of cannabis-infused products. The growth of the overall CBD-infused products market is backed by the rising demand and increasing legalization of cannabis, growing application of cannabis in cancer, and health benefits offered by cannabis-infused products. Moreover, the usage of cannabis in pet food and the increasing demand for cannabis-infused drinks provide significant opportunities in this market. However, the high cost associated with CBD and stringent government regulations against cannabis in certain countries obstructs the growth of this market to some extent. A report from Meticulous Research projected that the CBD-infused products market is expected to grow at a CAGR of 45.6% from 2021 to 2028 to reach $216.8 billion by 2028. The report said, "The COVID-19 pandemic has severely impacted many economies around the globe. As a measure to control the spread of this disease and avoid its associated consequences, governments across the globe announced partial or complete lockdowns, majorly impacting many industries, but the cannabis industry is having a breakthrough moment. Since it is beneficial for COVID-19 respiratory effects, thus state and local governments are gradually accepting the value and benefits of medicinal cannabis. Thus, this factor is expected to boost the demand for CBD-infused products." Active Companies in the cannabis industry include Grove, Inc. (NASDAQ: GRVI), Trulieve Cannabis Corp. (OTCQX: TCNNF) (CSE: TRUL), Curaleaf Holdings, Inc. (OTCQX: CURLF) (CSE: CURA), Cronos Group, Inc. (NASDAQ: CRON) (TSX: CRON), Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB).

Key Points: 
  • Nowadays, the demand for cannabis is expected to increase significantly from the arrival of cannabis-infused products.
  • The growth of the overall CBD-infused products market is backed by the rising demand and increasing legalization of cannabis, growing application of cannabis in cancer, and health benefits offered by cannabis-infused products.
  • As a result, CBD-infused product sales are soaring, ultimately driving the growth of the CBD-infused products market.
  • "According to Bloomberg , Thrasio, having raised more than $2 billion, could see its IPO valued at more than $10 billion.

Curaleaf to Report Third Quarter 2021 Financial and Operational Results

Thursday, September 30, 2021 - 10:50pm

Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ("Curaleaf") is a leading international provider of consumer products in cannabis with a mission to improve lives by providing clarity around cannabis and confidence around consumption.

Key Points: 
  • Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ("Curaleaf") is a leading international provider of consumer products in cannabis with a mission to improve lives by providing clarity around cannabis and confidence around consumption.
  • As a high-growth cannabis company known for quality, expertise and reliability, the Company and its brands, including Curaleaf and Select, provide industry-leading service, product selection and accessibility across the medical and adult-use markets.
  • In the United States, Curaleaf currently operates in 23 states with 109 dispensaries, 22 cultivation sites and over 30 processing sites, and employs over 5,000 team members.
  • Curaleaf is listed on the Canadian Securities Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF.

Curaleaf Announces Voting Results of its Annual and Special Meeting of Shareholders

Thursday, September 9, 2021 - 10:30pm

Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ("Curaleaf") is a leading international provider of consumer products in cannabis with a mission to improve lives by providing clarity around cannabis and confidence around consumption.

Key Points: 
  • Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ("Curaleaf") is a leading international provider of consumer products in cannabis with a mission to improve lives by providing clarity around cannabis and confidence around consumption.
  • Curaleaf is listed on the Canadian Securities Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF.
  • This news release contains forwardlooking statements and forwardlooking information within the meaning of applicable securities laws (collectively, "forward-looking statements").
  • We caution investors not to place undue reliance on the forward-looking statements contained in this news release.

American Green, Inc.™ (OTC:ERBB) Earns Five Year Cannabis Grow Management Contract from Curaleaf Holdings, Inc.

Wednesday, August 25, 2021 - 4:31pm

Curaleaf Holdings, Inc.(CSE: CURA) (OTCQX: CURLF) is a leading international provider of consumer products in cannabis which serves medical and adult-use customers throughout the state.

Key Points: 
  • Curaleaf Holdings, Inc.(CSE: CURA) (OTCQX: CURLF) is a leading international provider of consumer products in cannabis which serves medical and adult-use customers throughout the state.
  • David G. Gwyther, American Green's president said "We are proud to extend our relationship with Curaleaf Holdings, Inc. for five years.
  • American Green's premium cannabis is used in various Curaleaf and Select products, including some of their popular Live Resin offerings.
  • Shareholders and interest holders may also stay current with American Green Updates:
    In 2009, American Green, Inc.became America's second publicly-traded company in the cannabis sector.

American Green, Inc.™ (OTC:ERBB) Earns Five Year Cannabis Grow Management Contract from Curaleaf Holdings, Inc.

Wednesday, August 25, 2021 - 12:30pm

This agreement will provide American Green with approximately $2.1 million in annual revenue and $10.4 million in revenue over the term of the agreement.

Key Points: 
  • This agreement will provide American Green with approximately $2.1 million in annual revenue and $10.4 million in revenue over the term of the agreement.
  • David G. Gwyther, American Greens president, said, We are proud to extend our relationship with Curaleaf Holdings, Inc. for five years.
  • American Greens premium cannabis is used in various Curaleaf and Select products, including some of their popular Live Resin offerings.
  • Shareholders and interest holders may also stay current with American Green Updates:
    In 2009, American Green, Inc. became Americas second publicly-traded company in the cannabis sector.

Curaleaf Announces Presentation at the Canaccord Genuity 41st Annual Growth Conference

Wednesday, August 4, 2021 - 1:00pm

WAKEFIELD, Mass., Aug. 4, 2021 /PRNewswire/ -- Curaleaf Holdings, Inc. (CSE: CURA / OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer products in cannabis, today announced that Boris Jordan, Curaleaf Executive Chairman, will be presenting at the Canaccord Genuity 41st Annual Growth Conference on Tuesday, August 10, 2021 at 9:00 am ET.

Key Points: 
  • WAKEFIELD, Mass., Aug. 4, 2021 /PRNewswire/ -- Curaleaf Holdings, Inc. (CSE: CURA / OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer products in cannabis, today announced that Boris Jordan, Curaleaf Executive Chairman, will be presenting at the Canaccord Genuity 41st Annual Growth Conference on Tuesday, August 10, 2021 at 9:00 am ET.
  • The Curaleaf management team will also be conducting investor meetings in conjunction with the conference.
  • Details on how to access Curaleaf's live webcast presentation, as well as the replay, can be found under the events section of the Curaleaf investor relations website at https://ir.curaleaf.com/events .
  • Curaleaf is listed on the Canadian Securities Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF.

Curaleaf International Launches Second Medical Cannabis Flower Product for UK Market

Tuesday, July 27, 2021 - 7:00am

Curaleaf International (formerly EMMAC Life Sciences Group), (Curaleaf International), Europes largest vertically integrated cannabis company, is pleased to announce the launch of its second range of medical cannabis flower products for the UK market.

Key Points: 
  • Curaleaf International (formerly EMMAC Life Sciences Group), (Curaleaf International), Europes largest vertically integrated cannabis company, is pleased to announce the launch of its second range of medical cannabis flower products for the UK market.
  • The new products are being manufactured in the UK and will be an extension to Curaleaf Internationals existing range of medical cannabis flower and oil products.
  • Antonio Costanzo, CEO of Curaleaf International, commented: We are very pleased to extend our range of medical cannabis products for the UK market.
  • As a market leader, Curaleaf International is focused on solving the key patient and physician challenges relating to the price, accessibility, and sustainability of medical cannabis products.

Curaleaf Announces Opening of Branded Store in Wells, Maine

Friday, July 23, 2021 - 1:00pm

WAKEFIELD, Mass., July 23, 2021 /PRNewswire/ -- Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading U.S. provider of consumer products in cannabis, celebrates the opening of a new Curaleaf-branded medical location in Wells, located at 913 Post Rd., Wells, ME 04090. This is the company's fifth branded location in Maine (comprised of one adult-use and four medical locations) and its 108th nationwide.  

Key Points: 
  • This is the company's fifth branded location inMaine (comprised of one adult-use and four medical locations)and its 108th nationwide.
  • This is the first Curaleaf-branded store inWells, a popular tourist destination in Maine.
  • To celebrate the new location, Curaleaf Wells patients will receive 10% off their first purchase and have access to free delivery from July 23-25.
  • More particularly and without limitation, this news release contains forwardlooking statements and information concerning the opening of the Curaleaf Wells dispensary.